7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Cassava Sciences, Inc
(NASDAQ:SAVA) 

SAVA stock logo

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-b...

Founded: 1998
Full Time Employees: 9
CEO: Remi Barbier  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Cassava Sciences Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0360.33720.661,080.991,441.321,801.652,161.992,522.32
Cassava Sciences Days Receivable Outstanding ttm (DSO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -269.29-230.8-192.31-153.82-115.32-76.83-38.340.15Thousand
Cassava Sciences Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.96-1.68-1.4-1.12-0.84-0.56-0.280
Cassava Sciences Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.29-1.96-1.63-1.31-0.98-0.65-0.330
Cassava Sciences Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.790.070.931.82.663.524.385.25
Cassava Sciences P/S ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -568.72-487.41-406.11-324.81-243.5-162.2-80.890.41Thousand
Cassava Sciences (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -36.03-30.88-25.73-20.59-15.44-10.29-5.150
Cassava Sciences P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0126.39252.79379.18505.58631.97758.36884.76
No extra charts and metrics for this ticker.